Moreover, we analyzed scRNA-seq data from 44 fragments of tumor tissue (GSE182109) [17], and found PLK3 was highly expressed in MES cells, which was consistent with the analysis in pathology subtypes of GBM (Fig. S1H). This evidence concerns the gene PLK3 and glioblastoma.